Skip to main content
You are the reason a child is alive!

When Lorelai couldn’t perform tasks typical for a four-month-old, like rolling over or holding her head up, her parents became very concerned. They took her to the hospital, and a CT scan showed an enormous tumor on her brain. Lorelai had a high-grade glioma, a fast-growing tumor that spreads quickly and has a dire prognosis.

Despite risky surgery and six months of toxic chemotherapy, the tumor continued to grow.

Because traditional treatments were failing her, Lorelai’s doctors turned to CURE’s donor-funded Precision Medicine Program for answers. A sample of her tumor was sent for genetic analysis, and a specific mutation was identified. Fortunately, a drug exists that targets this mutation and stops tumor growth.

The results saved her life.

After two months of this new therapy, the residual tumor drastically reduced in size. Lorelai is now progressing in her age-related milestones, and with physical therapy, she is developing as she should. Her mother, Kathryn, said:

“This drug has been revolutionary for us.
It is essentially why my child is alive today.”

Your generosity to CURE gave Lorelai a most precious gift – the gift of life. This holiday season, you can give kids with cancer a gift more valuable than any toy —their best chance to beat their disease.

Please give today to bring us one step closer to a world without childhood cancer.


What Is Precision Medicine?

Every child is unique. Thanks to your support, their cancer treatments can be too.

Our focus on advancing the use of precision medicine to treat children with cancer launched in 2017 and has been our highest priority since then, with a total investment of $12 million.

An easy way to understand precision medicine is to think of it as “personalized medicine.” Although we know that every child is unique, today’s childhood cancer treatment does not take into account the genetic differences of each child. Rather, a child’s cancer is treated according to disease type. But often, children with the same type of cancer respond differently to the same treatment. A chemotherapy which is effective for some may fail altogether for others because of the genetic differences at play. That is where personalized medicine comes in.

The vision of precision medicine is to provide personalized, non-toxic, and curative therapy for all children with cancer by genetically mapping a child’s tumor and targeting the problem mutations. To achieve this aim, genetic testing seeks to identify targets that allow doctors to create individualized treatments to destroy the mutated cells.

Since our focus on precision medicine began, 85% of the children who received genetic mapping with CURE’s funding found their treatments impacted by the information obtained. But the impact of precision medicine goes well beyond the child’s cancer treatment. Genetic testing can change a diagnosis or reveal a genetic predisposition to cancer that can affect a family for generations.